North Hatley, Canada

Johannes E Van Lier


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1999-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Johannes E Van Lier

Introduction

Johannes E Van Lier is a notable inventor based in North Hatley, Canada. He has made significant contributions to the field of photodynamic therapy and radiopharmaceuticals. With a total of 3 patents, his work has advanced medical applications and diagnostic imaging.

Latest Patents

One of his latest patents is titled "Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine." This patent discloses novel trisulfonated tribenzo-mononahptho-porphyrazines, processes for making them, and their application as improved photosensitizing drugs for the treatment of various medical conditions by photodynamic therapy (PDT). These water-soluble amphiphilic porphyrazines are substituted with different alkylyl, aryl, aminoalkyl, and aminoaryl groups, with or without carboxyl moiety. Another significant patent is "Radiometal complexes of 2-pyrrolylthiones and their use as radiopharmaceuticals for imaging and therapy." This patent reveals novel 2-pyrrolylthione derived metal chelate compounds as imaging and therapeutic agents, along with compositions and methods for their preparation and use.

Career Highlights

Throughout his career, Johannes E Van Lier has worked with esteemed institutions, including the Université de Sherbrooke. His research has focused on innovative solutions in the medical field, particularly in enhancing therapeutic techniques.

Collaborations

He has collaborated with notable individuals such as Svetlana V Kudrevich and Sandra Gilbert, contributing to the advancement of his research and inventions.

Conclusion

Johannes E Van Lier's contributions to the fields of photodynamic therapy and radiopharmaceuticals highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to advancing healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…